| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |